| ASQIX | FSSNX | ASQIX / FSSNX | |
| Total Expense Ratio | 0.85 | 0.03 | 3,400% |
| Annual Report Gross Expense Ratio | 0.85 | 0.03 | 3,400% |
| Fund Existence | 28 years | 15 years | - |
| Gain YTD | 24.761 | 23.128 | 107% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 2500 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 194M | 34.1B | 1% |
| Annual Yield % from dividends | 0.09 | 1.06 | 8% |
| Returns for 1 year | 34.67 | 38.61 | 90% |
| Returns for 3 years | 54.08 | 64.68 | 84% |
| Returns for 5 years | 17.99 | 41.46 | 43% |
| Returns for 10 years | 72.42 | 149.27 | 49% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| BIB | 108.86 | 2.42 | +2.28% |
| ProShares Ultra Nasdaq Biotechnology | |||
| DIVN | 30.22 | 0.05 | +0.16% |
| Horizon Dividend Income ETF | |||
| HFEQ | 24.77 | 0.01 | +0.04% |
| Unlimited HFEQ Equity Long/Short ETF | |||
| RDIV | 62.50 | -0.14 | -0.22% |
| Invesco S&P Ultra Dividend Revenue ETF | |||
| BTCL | 12.28 | -0.40 | -3.18% |
| T-Rex 2X Long Bitcoin Daily Target ETF | |||